13th ISG | International Symposium of Gastroenterology

Date: 23-25/11/2023
Venue: Istanbul, Turkey
Attendees: 305

Topics

Antisecretory Therapy
Neuro-Motility Disorders
Fatty Liver
The Liver & Metabolic Syndrome
Biliary Strictures Cross-Talk
Inflammatory Bowel Disease

Registration fee €320 (incl. VAT).

It is important to note, that due to high demand and to capacity limits, participation requests may not be accepted.

ISG 2023

For download

Symposium photos

Session I : Antisecretory Therapy – Challenges from Daily Practice

Anti-secretory therapy in hospital and ambulatory patients

Different countries – different approaches in a treatment of reflux disease

PPIs adverse effects – facts or fiction?

Anti-secretory therapy and microbiome

Future directions (prokinetics, H2RA, PCABs)

Session II : Neuro-motility Disorders – Revealing the Clinical Consequences

East-European consensus on management of FD

Specialistic diagnostics of motility disorders of upper GIT – where are we?

And what about DGR

When GERD overlaps with dyspepsia

Hypersensitive esophagus

Session III : Biliary stricture Cross-Talk

PSC and other precancerous conditions – are they really out of reach?

Indeterminate biliary stricture – probe, FISH or scope?

Tissue is an issue – stricture through the microscope

Cholangiocarcinoma endoscopy therapy – heating and/or stenting

Surgical Treatment of Cholangiocarcinoma: Resection vs. Transplantation

Cholangiocarcinoma oncological therapy

Session IV : Fatty Liver – Deeper Insight Into the Burden of the Issue

SLD: Easy diagnostics of liver damage, experience

Liver enzymes and metabolites elevation an important factor in fatty liver disease

Bridging NAFLD and MAFLD: Current epidemiology and future trends

Different clinical manifestations of SLD

Session V : The Liver and Metabolic Syndrome – Shed Light on the Fatty Liver Disease

Fatty liver related co-morbidities

Liver, the silent culprit behind cardiovascular mortality

Liver and insulin resistance in type 2 diabetes

Metabolic dysfunction-associated steatotic liver disase (MASLD) and hepatocellular carcinoma (HCC): clinical challenges of an intriguing link

Liver Transplantation in Metabolic Syndrome

Session VI : Inflammatory Bowel Disease – Lessons from Real World Data

Endoscopic therapy of Crohn’s disease

Gastroenterological aspects of perinatal care in IBD – from guidelines to clinical practice?

IBD care: Western vs. Eastern Europe

Small molecules in the treatment of IBD

Strategies to optimized treatment outcomes in IBD